Skip to main content

Table 4 Distribution of serious adverse events across randomization groups

From: Early mechanical ventilation in patients with Guillain-Barré syndrome at high risk of respiratory failure: a randomized trial

  All patients
n = 50
Experimental group
N = 25
Control group
N = 25
p
In hospital death—yesa 3 (6) 1 (4) 2 (8) 1.00
Septic shock—yes 11 (22) 6 (30) 5 (25) 1.00
Acute renal failure—yes 2 (4) 0 (0) 2 (11) 0.22
Acute hepatic failure—yes 3 (6) 1 (5) 2 (10) 1.00
Acute respiratory distress syndrome— yes 13 (26) 7 (35) 6 (35) 1.00
  1. Data are expressed as number (percentage)
  2. aAt 90-days post-randomization, there were four deaths, with one patient who died after being discharge alive from hospital